JSPR:NASDAQ, Jasper Therapeutics, Inc.

Why JSPR stock fell on November 20

Jasper Therapeutics, Inc. fell 18.3% on Friday, November 20, 2026, on 11,716 shares. No headline about JSPR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

JSPR stock overview

Jasper Therapeutics, Inc. (JSPR:NASDAQ) closed at $8.69 on November 20, 2026, down 18.25% on the day. The stock trades 88.0% below its 52-week high of $72.60 and 2.6% above its 52-week low of $8.47. Over the past year, it lost 83.2%. Jasper Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$8.69
Day change
-18.25%
Volume
11,716
Average volume
17,114
Market cap
9M+
52-week range
$8.47 – $72.60
50-day average
$15.98
200-day average
$23.32

Price action over the past year

In 252 trading sessions since November 20, 2025, JSPR closed higher on 115 days (46%). Its best day was June 29, 2026 (+23.17%) and its worst was June 1, 2026 (-35.59%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

JSPR news

About Jasper Therapeutics, Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Similar stocks

Find more stocks like JSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.